Exploratory study of an intervention method using tomato juice to maintain/reduce the risk of disease for healthy people

Exploratory study of an intervention method using tomato juice to maintain/reduce the risk of disease for healthy people - Exploratory study of an intervention method using tomato juice to maintain/reduce the risk of disease for healthy people

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000053507

Enrollment

Registered

2024-02-01

Start date

2024-02-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CVD / lung cancer / dementia / chronic kidney disease / eye disease

Interventions

Consume 1 bottle (approx. 200 ml) of commercial tomato juice every morning for 12 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Those who have FonesVisuas test in March 2023 * However, if the number of participants in the study is small, this condition will be eliminated and recruitment will be conducted without it.

Exclusion criteria

Exclusion criteria: Exclude those who meet any of the following criteria 1-5 (1)Persons who are undergoing or have undergone treatment for lung cancer (2)Persons diagnosed with dementia (3)People with systemic lupus erythematosus (SLE) (4)Pregnant women (5)Persons who are unable to give their written or electromagnetic consent to participate in the research

Design outcomes

Primary

Measure	Time frame
The primary endpoint of this study will be the variable value of the risk of CVD after 12 weeks of tomato juice consumption.	—

Countries

Japan

Contacts

Public ContactKatsuyuki Nagai

Tohoku University Graduate School of Medicine Well-being Design Joint Research Chair

katsuyuki.nagai.e2@tohoku.ac.jp090-1451-5689

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026